Abstract
Alkaptonuria is a rare, hereditary metabolic disorder in which a deficiency in the homogentisate 1,2-dioxygenase enzyme results in an accumulation of homogentisic acid. Deposition of excess homogentisic acid in different intra- and extra-articular structures with high content of connective tissue causes brownish-black pigmentation and weakening, ultimately resulting in tissue degeneration and finally osteoarthritis. Ochronotic arthropathy is considered a rapidly progressive, disabling condition in which weight-bearing joints and the thoracolumbar spine are predominantly affected. Patients often require multiple joint replacements, such as in the case of the patient presented here. At present, there is no definitive cure for ochronosis, and management is predominantly symptomatic.
Similar content being viewed by others
References
Ranganath L, Taylor AM, Shenkin A, Fraser WD, Jarvis J, Gallagher JA, Sireau N (2011) Identification of alkaptonuria in the general population: a United Kingdom experience describing the challenges, possible solutions and persistent barriers. J Inherit Metab Dis 34(3):723–730
Phornphutkul C, Introne WJ, Perry MB, Bernardini I, Murphy M, Fitzpatrick D, Anderson PD, Huizing M, Anikster Y, Gerber LH, Gahl WA (2002) Natural history of alkaptonuria. N Engl J Med 347:2111–2121
Milch RA (1960) Studies of alkaptonuria: inheritance of 47 genes in highly inter-related Dominican kindreds. Am J Hum Genet 12:76–85
Zatkova A (2011) An update on molecular genetics of Alkaptonuria (AKU). J Inherit Metab Dis 34:1127–1136
Groseanu L, Marinescu R, Laptoiun D, Botezatu I, Staniceanu F, Zurac S, Ionescu R (2010) A late and difficult diagnosis of ochronosis. J Med Life 3:437–443
Rovenský J, Urbánek T, Stančíková M (2012) The clinical picture of alkaptonuria and ochronosis. Reumatologia 4:324–335
Helliwell TR, Gallagher JA, Ranganath L (2008) Alkaptonuria—a review of surgical and autopsy pathology. Histopathology 53:503–512
Ranganath R, Jarvis J, Gallagher J (2013) Recent advances in management of alkaptonuria. J Clin Pathol 66:367–373
Toth K, Lenart E, Janositz G, Takacs K (2003) Ochronotic arthropathy. Scand J Rheumatol 32(5):315–317
Laskar TH, Sarginson KD (1970) Ochronotic arthropathy—review of four cases. J Bone Joint Surg 52:653–655
Aliberti G, Pulignano I, Schiappoli A, Minisola S, Romagnoli E, Proietta M (2003) Bone metabolism in ochronotic patients. J Intern Med 254:296–300
Broman P, Bodur H, Ciliz D (2002) Ochronotic arthropathy. Rheumatol Int 21:205–209
La Du B (2002) Alkaptonuria. In: Royce RM, Steinman B (eds) Connective tissue and its heritable disorders: molecular, genetic and medical aspects. 2nd Ed. New York: Wiley-Liss, New York, pp 809–825
Ellaway CJ, Holme E, Standing S, Preece MA, Green A, Ploechl E, Ugarte M, Trefz FK, Leonard JV (2001) Outcome of tyrosinemia type III. J Inherit Metab Dis 24:824–832
Gandhi R, Bahri N, Parekh S, Chudasama S, Shah C, Darnia B (2010) Literature and MR findings in ochronosis. Gujarat Med J 65(1):39–46
Mannoni A, Selvi E, Lorenzini S, Giorgi M, Airo P, Cammelli D, Andreotti L, Marcolongo R, Porfirio B (2004) Alkaptonuria, ochronosis, and ochronotic arthropathy. Semin Arthritis Rheum 33:239–248
O’Brien WM, La Du BN, Bunim JJ (1963) Biochemical, pathological and clinical aspects of alkaptonuria, ochronosis and ochronotic arthropathy. Review of the world literature (1584–1962). Am J Med 34:813–838
Abate M, Schiavone C, Salini V, Andia I (2013) Occurrence of tendon pathologies in metabolic disorders. Rheumatology 52:599–608
Shah N, Goveas D, Khadilkar M (2012) A case of patellar tendon avulsion in an ochronotic patient and a review of the literature. JCR Indian J Med Case Rep 1:7–10
Filippou G, Frediani B, Selvi E, Bertoldi I, Galeazzi M (2008) Tendon involvement in patients with ochronosis: an ultrasonographic study. Ann Rheum Dis 67:1785–1786
Byers Kraus V (2008) Ochronosis, Kashin-Beck disease and Mseleni joint disease. In: Hochberg MC (ed) Rheumatology, 4th edn. Elsevier, Spain, pp 1791–1801
Perry MB, Suwannarat P, Furst G, Gahl W, Gerber L (2006) Musculoskeletal findings an disability in alkaptonuria. J Rheumatol 33:2280–2285
Sahin G, Milcan A, Baðiþ A, Köktürk A, Pata C, Erdoğan C (2001) A case of ochronosis: upper extremity involvement. Rheumatol Int 21:78–80
Resnick D (2002) Alkaptonuria. In: Resnick D (ed) Diagnosis of one and joint disorders. 4th ed. Philadelphia, PA, USA: W.B. Saunders Company, Philadelphia, PA, USA, pp 1686–1691
Koçyigit H, Gürgan A, Terzioglu R, Gürgan U (1998) Clinical, radiographic and echocardiographic findings in a patient with ochronosis. Clin Rheumatol 17(5):403–406
Keller JM, Macaulay W, Nercessian OA, Jaffe IA (2005) New developments in ochronosis: review of the literature. Rheumatol Int 2:81–85
Takagi M, Ida H, Kobayashi S, Ishii M, Osanai T, Konttinen YT (2003) Ochronotic spondyloarthropathy: two case reports of progressive destructive changes in the hip. Mod Rheumatol 13:81–86
Azhar A, Khan R, Smyth H (2007) Ochronotic arthritis. Int J Shoulder Surg 1:77–80
Shimizu I, Hamada T, Khalpey Z, Miyanishi K, Hara T (2007) Ochronotic arthropathy: pathological evidence of acute destruction of the hip joint. Clin Rheumatol 26:1189–1191
Steinger U, Lagier R (1973) Combined anatomical and radiological study of the hip-joint in alkaptonuric arthropathy. Ann Rheum Dis 31:369–373
Lagier R (1980) The concept of osteoarthritic remodeling as illustrated by ochronotic arthropathy of the hip. An anatomic-radiological approach. Virchow Arch A Pathol Anat Histol 385:293–308
Lagier R, Baud CH, Lacotte D, Cunningham T (1988) Rapidly progressive osteoarthrosis of ochronotic origin. Am J Clin Pathol 90:95–102
Lequesne M (1993) Rapidly progressing destructive diseases of the hip. Ann Radiol (Paris) 36:62–64
Corra T, Zaccala M, Galante M (1995) Ochronotic arthropathy: rapidly destructive hip osteoarthritis associated with metabolic disease. Clin Rheumatol 14:474–477
Kruithof E, Baeten D, Veys EM, De Keyser F, Suykens S, De Wilde L, Verdonk R (2004) Case Number 29: Ochronosis: synovial histopathological characteristics. (Abstract). Ann Rheum Dis 6:130
Bayindir P, Yilmaz Ovali G, Pabuşçu Y, Temiz C, Duruoz T (2006) Radiologic features of lumbar spine in ochronosis in late stages. Clin Rheumatol 25:588–590
Iannuccelli C, Coari G, Mastantuono M, Osimani M, Valesini G, Di Franco M (2009) Joint and tendineous involvement in ochronosis: clinical history and imaging of a case. Clin Exp Rheumatol 27:696–697
Hamdulay SS, Finegold J, Boyer L, Khanna M, Akmal M, Walker A, Kinderlerer A (2012) Clinical images: magnetic resonance imaging appearance of alkaptonuria. (Abstract). Arthritis Rheum 64:129
Vinjamuri S, Ramesh CN, Jarvis J, Gallagher JA, Ranganath LL (2011) Nuclear medicine techniques in the assessment of alkaptonuria. Nucl Med Commun 32:880–886
McClure J, Smith PS, Gramp AA (1983) Calcium pyrophosphate dihydrate (CPPD) deposition in ochronotic arthropathy. J Clin Pathol 36:894–902
Preston AJ, Keenan CM, Sutherland H, Wilson PJ, Wlodarski B, Taylor AM, Williams DP, Ranganath LR, Gallagher JA, Jarvis JC (2014) Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone. Ann Rheum Dis 73:284–289
Disclosures
All authors declare no conflicts of interest.
Ventura-Ríos L. None.
Hernández-Díaz C. None.
Gutiérrez-Pérez L. None.
Bernal-González A. None.
Pichardo-Bahena R. None.
Cedeño-Garcidueñas A. None.
Pineda C. None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ventura-Ríos, L., Hernández-Díaz, C., Gutiérrez-Pérez, L. et al. Ochronotic arthropathy as a paradigm of metabolically induced degenerative joint disease. A case-based review. Clin Rheumatol 35, 1389–1395 (2016). https://doi.org/10.1007/s10067-014-2557-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-014-2557-7